Skip to main content

Search

91 result(s) for 'author#"Delong Liu"' within BMC

Page 1 of 5

Sort by: Relevance | Date

  1. A1 Proceedings of 2016 China Cancer Immunotherapy Workshop, Beijing, China

    Authors: Bin Xue, Jiaqi Xu, Wenru Song, Zhimin Yang, Ke Liu, Zihai Li, Zihai Li, Lieping Chen, Edward B. Garon, Siwen Hu-Lieskovan, Wei Ding, Chong-Xian Pan, Weijing Sun, Yong-Jun Liu, Lei Zheng, Delong Liu…

    Citation: Journal of Hematology & Oncology 2016 9(Suppl 1):104

    Content type: Meeting abstracts

    Published on:

    This article is part of a Supplement: Volume 9 Supplement 1

  4. The original article [1] contains an error in the legend of Fig. 1 whereby it is incorrectly stated that MEC stands for ‘mitoprostate cancer using magnetic resonance imagingxantrone, etoposide, cyclophosphamid...

    Authors: Juanjuan Zhao, Yongping Song and Delong Liu

    Citation: Biomarker Research 2019 7:21

    Content type: Correction

    Published on:

    The original article was published in Biomarker Research 2019 7:19

  5. Burkitt's lymphoma (BL) is a heterogeneous group of highly aggressive mature B-cell malignancies. It is characterized by a high rate of turnover of malignant cells and deregulation of the c-myc gene. It is typ...

    Authors: Delong Liu, Josif Shimonov, Suneeta Primanneni, Yongrong Lai, Tauseef Ahmed and Karen Seiter

    Citation: Molecular Cancer 2007 6:35

    Content type: Short communication

    Published on:

  7. ABVD regimen (doxorubicin, bleomycin, vinblastine and dacarbazine) remains the most commonly used front-line therapy for Hodgkin lymphoma. However, atypical and extranodal presentations present challenges to i...

    Authors: Keyur Thakar, Aileen Novero, Arundhati Das, Adriana Lisinschi, Bella Mehta, Tauseef Ahmed and Delong Liu

    Citation: Biomarker Research 2014 2:12

    Content type: Case report

    Published on:

  8. Liposomal formulations of anthracyclines appear to have favorable toxicity profile when compared with conventional anthracyclines in elderly, high risk cardiac patients and patients with prior use of anthracyc...

    Authors: Shamudheen M Rafiyath, Mohammad Rasul, Byung Lee, Guoqing Wei, Gurpreet Lamba and Delong Liu

    Citation: Experimental Hematology & Oncology 2012 1:10

    Content type: Research

    Published on:

  10. Combination of phenethyl isothiocyanate (PEITC) and paclitaxel (taxol) has been shown to work synergistically to increase apoptosis and cell cycle arrest in breast cancer cells. In this report, we further expl...

    Authors: Shundong Cang, Yuehua Ma, Jen-wei Chiao and Delong Liu

    Citation: Experimental Hematology & Oncology 2014 3:5

    Content type: Research

    Published on:

  12. Research over the role of Bruton’s agammaglobulinemia tyrosine kinase (BTK) in B-lymphocyte development, differentiation, signaling and survival has led to better understanding of the pathogenesis of B-cell ma...

    Authors: Aileen Novero, Pavan M Ravella, Yamei Chen, George Dous and Delong Liu

    Citation: Experimental Hematology & Oncology 2014 3:4

    Content type: Review

    Published on:

  13. Extramedullary hematopoeisis (EMH) can occur in various physiological and pathologic states. The spleen is the most common site of EMH.

    Authors: Tasleem Katchi, Krishna Kolandaivel, Pallavi Khattar, Taliya Farooq, Humayun Islam and Delong Liu

    Citation: Biomarker Research 2016 4:17

    Content type: Case report

    Published on:

  14. CD20 negative B cell non-Hodgkin lymphoma (NHL) is rare and accounts for approximately 1-2% of B cell lymphomas. CD20- negative NHL is frequently associated with extranodal involvement, atypical morphology, ag...

    Authors: Tasleem Katchi and Delong Liu

    Citation: Biomarker Research 2017 5:5

    Content type: Review

    Published on:

  15. Histone deacetylase (HDAC) inhibitors are a new class of chemotherapeutic agents. Our laboratory has recently reported that phenylhexyl isothiocyanate (PHI), a synthetic isothiocyanate, is an inhibitor of HDAC...

    Authors: Quanyi Lu, Xianghua Lin, Jean Feng, Xiangmin Zhao, Ruth Gallagher, Marietta Y Lee, Jen-Wei Chiao and Delong Liu

    Citation: Journal of Hematology & Oncology 2008 1:6

    Content type: Research

    Published on:

  16. Babesiosis is endemic in selected areas in North America. Babesia infection is commonly associated with anemia, thrombocytopenia, hyponatremia and elevated liver enzymes. Autoimmune hemolytic anemia (AIHA) is ...

    Authors: Roshni Narurkar, Aleksandra Mamorska-Dyga, John C. Nelson and Delong Liu

    Citation: Biomarker Research 2017 5:14

    Content type: Case report

    Published on:

  18. Tumor-associated antigens (TAA) or cancer biomarkers are major targets for cancer therapies. Antibody- based agents targeting the cancer biomarkers include monoclonal antibodies (MoAbs), radiolabeled MoAbs, bi...

    Authors: Delong Liu

    Citation: Biomarker Research 2019 7:25

    Content type: Editorial

    Published on:

  19. Advanced malignant melanoma remains a challenging cancer. Over the past year, there have been 3 agents approved for treatment of melanoma by Food and Drug Administration. These include pegylated interferon alp...

    Authors: Byung Lee, Nikhil Mukhi and Delong Liu

    Citation: Journal of Hematology & Oncology 2012 5:3

    Content type: Review

    Published on: